Latest Stock Market News

An ET poll of 20 economists pegged growth in the January-March period in the 4.1-5.7% range with the median at 5.1%, higher than the 4.4% recorded in the preceding quarter.

Bidding for the debt sale is likely to be held from 11:00 am to 12:15 pm IST on Monday, May 29, on the BSE bond platform, sources said. The bonds are rated AAA by ICRA and India Ratings.

Registrations for external commercial borrowing (ECB) by corporates fell to $26.6bn in the last fiscal year due to rising global interest rates. After gradually increasing during the first three quarters of 2022-23, registrations dropped in Q4. ECB inflows for the year totalled $23.8bn, only marginally higher than outflows.

Boston Federal Reserve President, Susan Collins, suggests a pause in raising interest rates to evaluate the effect of past interest rate hikes on economic activity. Inflation remains high, however, there are early signs of moderation; the Federal Open Market Committee (FOMC) may pause from raising interest rates given the restrained banking sector and calm inflation. The next FOMC meeting is due to take place on 13-14 June and a pause will allow a complete evaluation of the information available at the time. However, many reserve officials still reserve the possibility of taking action if needed.

For more such web stories click on the ET icon below

Auto segment revenues increased 32% year-on-year, led by volumes and ASP. FES revenues to increase 24% YoY on 23% YoY increase in volumes and flat ASPs. Overall EBITDA margin to improve 20 bps QoQ to 13.2% on price hikes, offset by weak mix.

Equity markets ended with marginal gains on Thursday, apart from Oil & Gas, PSU Bank and Financials sectors. The US debt ceiling uncertainty and a stronger dollar weighed on investors’ sentiments. Ajit Mishra, VP - Technical Research, Religare Broking, said the index consolidation may continue, citing mixed indications. Traders should focus on handling intermediate volatility, look for opportunities in trends, and focus on sector stocks showing consistency in their trend instead of betting on laggards.

On like-to-like financials, the CDMO business that contributes 57% of revenues, declined 8% YoY to Rs 2164 crore. The complex hospital generics business grew 28% due to strong demand for the inhalation anesthesia portfolio. The consumer health business sales rose 5% to Rs 206 crores driven by sustained marketing and brand building efforts

The US business reported a third consecutive quarter of over $60 million in revenues in Q4FY23, while other regulated markets recorded the highest quarterly sales of $48 million. The company attributed the US sales to new product introductions and solid base performance,

The Nasdaq Composite rose 222.28 points, or 1.78%, to 12,706.44 at the opening bell